Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Glutamate-glutamine homeostasis is perturbed in neurons and astrocytes derived from patient iPSC models of frontotemporal dementia

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Transcriptomic profiling of trigeminal nucleus caudalis and spinal cord dorsal horn

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. DNMT1 regulates expression of MHC class i in post-mitotic neurons

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Brain Derived Neurotrophic Factor: epigenetic regulation in psychiatric disorders

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Paroxysmal Cranial Dyskinesia and Nail-Patella Syndrome Caused by a Novel Variant in the LMX1B Gene

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Mania triggered by levodopa treatment in a patient with frontotemporal dementia caused by A C9orf72 repeat expansion: A case report

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Enhancement of Autophagy and Solubilization of Ataxin-2 Alleviate Apoptosis in Spinocerebellar Ataxia Type 2 Patient Cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Blanca I Aldana
  • Yu Zhang
  • Pia Jensen
  • Abinaya Chandrasekaran
  • Sofie K Christensen
  • Troels T Nielsen
  • Jørgen E Nielsen
  • Poul Hyttel
  • Martin R Larsen
  • Helle S Waagepetersen
  • Kristine K Freude
View graph of relations

Frontotemporal dementia (FTD) is amongst the most prevalent early onset dementias and even though it is clinically, pathologically and genetically heterogeneous, a crucial involvement of metabolic perturbations in FTD pathology is being recognized. However, changes in metabolism at the cellular level, implicated in FTD and in neurodegeneration in general, are still poorly understood. Here we generate induced human pluripotent stem cells (hiPSCs) from patients carrying mutations in CHMP2B (FTD3) and isogenic controls generated via CRISPR/Cas9 gene editing with subsequent neuronal and glial differentiation and characterization. FTD3 neurons show a dysregulation of glutamate-glutamine related metabolic pathways mapped by 13C-labelling coupled to mass spectrometry. FTD3 astrocytes show increased uptake of glutamate whilst glutamate metabolism is largely maintained. Using quantitative proteomics and live-cell metabolic analyses, we elucidate molecular determinants and functional alterations of neuronal and glial energy metabolism in FTD3. Importantly, correction of the mutations rescues such pathological phenotypes. Notably, these findings implicate dysregulation of key enzymes crucial for glutamate-glutamine homeostasis in FTD3 pathogenesis which may underlie vulnerability to neurodegeneration. Graphical abstract: Neurons derived from human induced pluripotent stem cells (hiPSCs) of patients carrying mutations in CHMP2B (FTD3) display major metabolic alterations compared to CRISPR/Cas9 generated isogenic controls. Using quantitative proteomics, 13C-labelling coupled to mass spectrometry metabolic mapping and seahorse analyses, molecular determinants and functional alterations of neuronal and astrocytic energy metabolism in FTD3 were characterized. Our findings implicate dysregulation of glutamate-glutamine homeostasis in FTD3 pathogenesis. In addition, FTD3 neurons recapitulate glucose hypometabolism observed in FTD patient brains. The impaired mitochondria function found here is concordant with disturbed TCA cycle activity and decreased glycolysis in FTD3 neurons. FTD3 neuronal glutamine hypermetabolism is associated with up-regulation of PAG expression and, possibly, ROS production. Distinct compartments of glutamate metabolism can be suggested for the FTD3 neurons. Endogenous glutamate generated from glutamine via PAG may enter the TCA cycle via AAT (left side of neuron) while exogenous glutamate taken up from the extracellular space may be incorporated into the TCA cycle via GDH (right side of the neuron) FTD3 astrocytic glutamate uptake is upregulated whilst glutamate metabolism is largely maintained. Finally, pharmacological reversal of glutamate hypometabolism manifesting from decreased GDH expression should be explored as a novel therapeutic intervention for treating FTD3. [Figure not available: see fulltext.]

Original languageEnglish
Article number125
JournalMolecular Brain
Volume13
Issue number1
Pages (from-to)125
ISSN0006-8993
DOIs
Publication statusPublished - 14 Sep 2020

Bibliographical note

Publisher Copyright:
© 2020 The Author(s).

Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.

    Research areas

  • CHMP2B, FTD3, GC-MS, GDH, Glucose metabolism, Glutamate, Glutamine, GS, iPSC-derived neuron, PAG

ID: 61264798